Halidou Tinto
#126,987
Most Influential Person Now
Researcher, ORCID id # 0000-0002-0472-3586
Halidou Tinto's AcademicInfluence.com Rankings
Halidou Tintocomputer-science Degrees
Computer Science
#11775
World Rank
#12528
Historical Rank
Machine Learning
#5416
World Rank
#5487
Historical Rank
Artificial Intelligence
#5843
World Rank
#5932
Historical Rank
Database
#8859
World Rank
#9307
Historical Rank
Download Badge
Computer Science
Why Is Halidou Tinto Influential?
(Suggest an Edit or Addition)According to Wikipedia, Halidou Tinto is a Professor of parasitology and global health scientist with research that has contributed to understanding and combating malaria in Sub-Saharan Africa. Tinto founded the Clinical Research Unit of Nanaro in Burkina Faso as part of the Institut de Recherche en Sciences de la Santé . Tinto is now the Regional Director of the IRSS, and throughout his career he has contributed to the study of antimalarial drug resistance and the development of malaria vaccines.
Halidou Tinto's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. (2012) (689)
- First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. (2011) (531)
- Enabling the genomic revolution in Africa (2014) (327)
- Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine. (2015) (287)
- Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial (2015) (233)
- Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority Trial (2009) (146)
- Rapid malaria diagnostic tests vs. clinical management of malaria in rural Burkina Faso: safety and effect on clinical decisions. A randomized trial (2009) (124)
- Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial (2007) (124)
- A Head-to-Head Comparison of Four Artemisinin-Based Combinations for Treating Uncomplicated Malaria in African Children: A Randomized Trial (2011) (111)
- Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial (2021) (110)
- Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy (2019) (107)
- Regional and Sex Differences in the Prevalence and Awareness of Hypertension: An H3Africa AWI-Gen Study Across 6 Sites in Sub-Saharan Africa. (2017) (105)
- Accuracy of a rapid diagnostic test on the diagnosis of malaria infection and of malaria - attributable fever during low and high transmission season in Burkina Faso (2010) (87)
- Failure to detect Plasmodium vivax in West and Central Africa by PCR species typing (2008) (86)
- H3Africa AWI-Gen Collaborative Centre: a resource to study the interplay between genomic and environmental risk factors for cardiometabolic diseases in four sub-Saharan African countries (2016) (84)
- An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso (2012) (82)
- Profile: Nanoro Health and Demographic Surveillance System. (2012) (80)
- Pyronaridine-artesunate versus mefloquine plus artesunate for malaria. (2012) (79)
- Frequency of Severe Malaria and Invasive Bacterial Infections among Children Admitted to a Rural Hospital in Burkina Faso (2014) (77)
- Phylogenomic Analysis Reveals an Asian Origin for African Burkholderia pseudomallei and Further Supports Melioidosis Endemicity in Africa (2016) (77)
- Four artemisinin-based treatments in African pregnant women with malaria. (2016) (75)
- The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data. (2015) (65)
- Genomic and environmental risk factors for cardiometabolic diseases in Africa: methods used for Phase 1 of the AWI-Gen population cross-sectional study (2018) (61)
- Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention. (2021) (58)
- In-vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, dihydroartemisinin and quinine in an area of high chloroquine resistance in Rwanda. (2006) (57)
- Antigen persistence of rapid diagnostic tests in pregnant women in Nanoro, Burkina Faso, and the implications for the diagnosis of malaria in pregnancy (2012) (55)
- Artemisinin resistance in rodent malaria - mutation in the AP2 adaptor μ-chain suggests involvement of endocytosis and membrane protein trafficking (2013) (55)
- First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: A meta-analysis of observational studies (2017) (54)
- Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study. (2015) (54)
- Chloroquine‐resistance molecular markers (Pfcrt T76 and Pfmdr‐1 Y86) and amodiaquine resistance in Burkina Faso (2008) (52)
- Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso (2016) (49)
- Diagnosis of Bacterial Bloodstream Infections: A 16S Metagenomics Approach (2016) (45)
- Direct Blood PCR in Combination with Nucleic Acid Lateral Flow Immunoassay for Detection of Plasmodium Species in Settings Where Malaria Is Endemic (2012) (45)
- Relationship between the Pfcrt T76 and the Pfmdr-1 Y86 mutations in Plasmodium falciparum and in vitro/in vivo chloroquine resistance in Burkina Faso, West Africa. (2003) (44)
- Accuracy of PfHRP2 versus Pf-pLDH antigen detection by malaria rapid diagnostic tests in hospitalized children in a seasonal hyperendemic malaria transmission area in Burkina Faso (2014) (44)
- Evaluation of antigen detection tests, microscopy, and polymerase chain reaction for diagnosis of malaria in peripheral blood in asymptomatic pregnant women in Nanoro, Burkina Faso. (2012) (43)
- Effect of Adding Azithromycin to Seasonal Malaria Chemoprevention. (2019) (42)
- Antiplasmodial compounds from Cochlospermum tinctorium. (2002) (40)
- Malaria, malnutrition, and birthweight: A meta-analysis using individual participant data (2017) (40)
- Sulfadoxine-pyrimethamine efficacy and selection of Plasmodium falciparum DHFR mutations in Burkina Faso before its introduction as intermittent preventive treatment for pregnant women. (2007) (40)
- Could the Decision of Trial Participation Precede the Informed Consent Process? Evidence From Burkina Faso (2013) (39)
- A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria (2017) (38)
- Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa (2019) (37)
- Genetically diverse Plasmodium falciparum infections, within-host competition and symptomatic malaria in humans (2019) (35)
- In Vivo Selection of Plasmodium falciparum Pfcrt and Pfmdr1 Variants by Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine in Burkina Faso (2014) (35)
- Four Artemisinin-Based Treatments in African Pregnant Women with Malaria. (2016) (34)
- Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso. (2014) (34)
- Chloroquine and sulphadoxine‐pyrimethamine efficacy for uncomplicated malaria treatment and haematological recovery in children in Bobo‐Dioulasso, Burkina Faso during a 3‐year period 1998–2000 (2002) (34)
- Strict adherence to malaria rapid test results might lead to a neglect of other dangerous diseases: a cost benefit analysis from Burkina Faso (2011) (32)
- Towards Improving Point-of-Care Diagnosis of Non-malaria Febrile Illness: A Metabolomics Approach (2016) (32)
- Socioeconomic and environmental factors associated with malaria hotspots in the Nanoro demographic surveillance area, Burkina Faso (2019) (31)
- Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial. (2019) (31)
- A multinational Delphi consensus to end the COVID-19 public health threat (2022) (31)
- Regional and sex-specific variation in BMI distribution in four sub-Saharan African countries: The H3Africa AWI-Gen study (2018) (30)
- Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine (2017) (30)
- Clinical signs and symptoms cannot reliably predict Plasmodium falciparum malaria infection in pregnant women living in an area of high seasonal transmission (2013) (29)
- Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017–2018 (2021) (29)
- Accuracy of a Plasmodium falciparum specific histidine-rich protein 2 rapid diagnostic test in the context of the presence of non-malaria fevers, prior anti-malarial use and seasonal malaria transmission (2017) (28)
- High prevalence of hepatitis B infections in Burkina Faso (1996–2017): a systematic review with meta-analysis of epidemiological studies (2018) (28)
- Effectiveness of artesunate–amodiaquine vs. artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in Nanoro, Burkina Faso: a non‐inferiority randomised trial (2014) (28)
- The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data. (2015) (27)
- Treatable causes of fever among children under five years in a seasonal malaria transmission area in Burkina Faso (2018) (27)
- In vitro and in vivo antiplasmodial activity of ‘Saye’, an herbal Remedy used in Burkina Faso traditional medicine (2008) (26)
- Population-based incidence, seasonality and serotype distribution of invasive salmonellosis among children in Nanoro, rural Burkina Faso (2017) (26)
- Performance of OptiMAL‐IT® compared to microscopy, for malaria detection in Burkina Faso (2009) (25)
- Community-based scheduled screening and treatment of malaria in pregnancy for improved maternal and infant health in The Gambia, Burkina Faso and Benin: study protocol for a randomized controlled trial (2014) (25)
- Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes (2010) (25)
- Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine–pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso (2017) (25)
- Increase in the prevalence of mutations associated with sulfadoxine–pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso (2017) (24)
- Supporting evidence for a human reservoir of invasive non-Typhoidal Salmonella from household samples in Burkina Faso (2019) (24)
- Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change (2014) (24)
- Modulation of innate immune responses at birth by prenatal malaria exposure and association with malaria risk during the first year of life (2018) (24)
- Participation in medical research as a resource‐seeking strategy in socio‐economically vulnerable communities: call for research and action (2015) (23)
- Effectiveness and safety of artemether–lumefantrine versus artesunate–amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial (2015) (23)
- Randomised controlled trial of two sequential artemisinin-based combination therapy regimens to treat uncomplicated falciparum malaria in African children: a protocol to investigate safety, efficacy and adherence (2017) (23)
- Community-based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-randomized Controlled Trial (2018) (23)
- Determinants of Plasmodium falciparum multiplicity of infection and genetic diversity in Burkina Faso (2020) (22)
- Diagnosing congenital malaria in a high-transmission setting: clinical relevance and usefulness of P. falciparum HRP2-based testing (2017) (22)
- Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial. (2022) (21)
- Host-mediated selection impacts the diversity of Plasmodium falciparum antigens within infections (2018) (21)
- The XN-30 hematology analyzer for rapid sensitive detection of malaria: a diagnostic accuracy study (2019) (21)
- Excess risk of preterm birth with periconceptional iron supplementation in a malaria endemic area: analysis of secondary data on birth outcomes in a double blind randomized controlled safety trial in Burkina Faso (2019) (21)
- Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique (2015) (20)
- Spatial distribution and determinants of asymptomatic malaria risk among children under 5 years in 24 districts in Burkina Faso (2018) (20)
- Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countries (2017) (20)
- Clinical management and mortality among COVID-19 cases in sub-Saharan Africa: A retrospective study from Burkina Faso and simulated case analysis (2020) (20)
- The impact of clinical research activities on communities in rural Africa: the development of the Clinical Research Unit of Nanoro (CRUN) in Burkina Faso (2014) (19)
- Usefulness of the Plasmodium falciparum chloroquine resistance transporter T76 genotype failure index for the estimation of in vivo chloroquine resistance in Burkina Faso. (2005) (19)
- Paracheck® rapid diagnostic test for detecting malaria infection in under five children: a population-based survey in Burkina Faso (2014) (19)
- The assessment of gestational age: a comparison of different methods from a malaria pregnancy cohort in sub-Saharan Africa (2019) (19)
- Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis (2020) (18)
- The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data (2020) (18)
- Malaria incidence and prevalence during the first year of life in Nanoro, Burkina Faso: a birth-cohort study (2018) (18)
- Prevalence of the dhfr and dhps Mutations among Pregnant Women in Rural Burkina Faso Five Years after the Introduction of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine (2015) (18)
- H 3 Africa AWI-Gen Collaborative Centre : a resource to study the interplay between genomic and environmental risk factors for cardiometabolic diseases in four sub-Saharan African countries (2016) (18)
- Classical Cardiovascular Risk Factors and HIV are Associated With Carotid Intima‐Media Thickness in Adults From Sub‐Saharan Africa: Findings From H3Africa AWI‐Gen Study (2019) (18)
- Challenges of non‐commercial multicentre North‐South collaborative clinical trials (2013) (18)
- Effects of long-term weekly iron and folic acid supplementation on lower genital tract infection – a double blind, randomised controlled trial in Burkina Faso (2017) (18)
- Multi-Country Evaluation of Safety of Dihydroartemisinin/Piperaquine Post-Licensure in African Public Hospitals with Electrocardiograms (2016) (17)
- Aetiologies of non‐malaria febrile episodes in children under 5 years in sub‐Saharan Africa (2016) (17)
- Good clinical practice in resource-limited settings: translating theory into practice. (2013) (16)
- The effect of malaria rapid diagnostic tests results on antimicrobial prescription practices of health care workers in Burkina Faso (2019) (16)
- Effects of Weekly Iron and Folic Acid Supplements on Malaria Risk in Nulliparous Women in Burkina Faso: A Periconceptional, Double-Blind, Randomized Controlled Noninferiority Trial (2018) (16)
- It is time to revise the international Good Clinical Practices guidelines: recommendations from non-commercial North–South collaborative trials (2016) (16)
- Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities (2021) (15)
- A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria (2021) (15)
- Evaluation of Malaria Screening during Pregnancy with Rapid Diagnostic Tests Performed by Community Health Workers in Burkina Faso. (2017) (15)
- “There is Iron and Iron…” Burkinabè Women’s Perceptions of Iron Supplementation: A Qualitative Study (2014) (14)
- High Efficacy of a Low Dose Candidate Malaria Vaccine, R21 in 1 Adjuvant Matrix-M™, with Seasonal Administration to Children in Burkina Faso (2021) (14)
- Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017–2018 (2021) (13)
- Malaria mortality estimates: need for agreeable approach (2013) (13)
- Artemisinin-based combination therapy during pregnancy: outcome of pregnancy and infant mortality: a cohort study (2019) (13)
- The changing epidemiology of hepatitis B and C infections in Nanoro, rural Burkina Faso: a random sampling survey (2020) (13)
- In vitro sensitivity of Plasmodium falciparum to halofantrine compared with chloroquine, quinine and mefloquine in the region of Bobo-Dioulasso, Burkina Faso (West Africa). (1998) (13)
- Evaluation of seasonal malaria chemoprevention in two areas of intense seasonal malaria transmission: Secondary analysis of a household-randomised, placebo-controlled trial in Houndé District, Burkina Faso and Bougouni District, Mali (2020) (13)
- Health research: the challenges related to ethical review and informed consent in developing countries. (2010) (13)
- Prevalence and factors associated with overweight and obesity among rural and urban women in Burkina Faso (2019) (13)
- Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-based treatment for uncomplicated falciparum malaria in pregnancy: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis (2020) (13)
- Short- and long-read metagenomics of urban and rural South African gut microbiomes reveal a transitional composition and undescribed taxa (2022) (13)
- Malaria early in the first pregnancy: Potential impact of iron status. (2020) (13)
- Mucosal lactoferrin response to genital tract infections is associated with iron and nutritional biomarkers in young Burkinabé women (2019) (13)
- Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial. (2017) (12)
- Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial (2018) (12)
- Bayesian Spatiotemporal Modeling of Routinely Collected Data to Assess the Effect of Health Programs in Malaria Incidence During Pregnancy in Burkina Faso (2020) (12)
- In vivo/ex vivo efficacy of artemether–lumefantrine and artesunate–amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso (2020) (12)
- Dynamic of plasmodium falciparum chloroquine resistance transporter gene Pfcrt K76T mutation five years after withdrawal of chloroquine in Burkina Faso (2015) (12)
- Safety Profile of Drug Use During Pregnancy at Peripheral Health Centres in Burkina Faso: A Prospective Observational Cohort Study (2018) (12)
- Clinical presentation, outcomes and factors associated with mortality: A prospective study from three COVID-19 referral care centres in West Africa (2021) (12)
- Implementation of a malaria rapid diagnostic test in a rural setting of Nanoro, Burkina Faso: from expectation to reality (2018) (11)
- Smokeless tobacco use: its prevalence and relationships with dental symptoms, nutritional status and blood pressure among rural women in Burkina Faso (2019) (11)
- Should Malaria Treatment Be Guided by a Point of Care Rapid Test? A Threshold Approach to Malaria Management in Rural Burkina Faso (2013) (11)
- Strength in Numbers: The WWARN Case Study of Purpose-Driven Data Sharing (2018) (11)
- Low Birth Weight and Prematurity in Teenage Mothers in Rural Areas of Burkina Faso (2017) (11)
- Paediatric Pharmacovigilance: Use of Pharmacovigilance Data Mining Algorithms for Signal Detection in a Safety Dataset of a Paediatric Clinical Study Conducted in Seven African Countries (2014) (11)
- Gender differences in sociodemographic and behavioural factors associated with BMI in an adult population in rural Burkina Faso – an AWI-Gen sub-study (2018) (11)
- Novel and Known Gene-Smoking Interactions With cIMT Identified as Potential Drivers for Atherosclerosis Risk in West-African Populations of the AWI-Gen Study (2020) (10)
- Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01E vaccine, seasonal malaria chemoprevention and the combination of vaccination and chemoprevention (2020) (10)
- Aetiology of acute febrile illness in children in a high malaria transmission area in West Africa. (2020) (10)
- Impact of retreatment with an artemisinin-based combination on malaria incidence and its potential selection of resistant strains: study protocol for a randomized controlled clinical trial (2013) (10)
- Malaria prevention measures in Burkina Faso: distribution and households expenditures (2014) (9)
- Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa (2019) (8)
- Fear and rumours regarding placental biopsies in a malaria-in-pregnancy trial in Benin (2018) (8)
- Optimal Approach and Strategies to Strengthen Pharmacovigilance in Sub-Saharan Africa: A Cohort Study of Patients Treated with First-Line Artemisinin-Based Combination Therapies in the Nanoro Health and Demographic Surveillance System, Burkina Faso (2020) (8)
- Community approval required for periconceptional adolescent adherence to weekly iron and/or folic acid supplementation: a qualitative study in rural Burkina Faso (2018) (8)
- Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®) (2015) (8)
- Asymptomatic malaria and anaemia among pregnant women during high and low malaria transmission seasons in Burkina Faso: household-based cross-sectional surveys in Burkina Faso, 2013 and 2017 (2020) (8)
- First trimester use of artemisinin-based combination therapy and the risk of low birth weight and small for gestational age (2020) (8)
- ‘Men are not playing their roles’, maternal and child nutrition in Nanoro, Burkina Faso (2020) (8)
- In Vivo Antiplasmodial Activity of Two Sahelian Plant Extracts on Plasmodium berghei ANKA Infected NMRI Mice (2018) (8)
- The Duration of Protection from Azithromycin Against Malaria, Acute Respiratory, Gastrointestinal, and Skin Infections When Given Alongside Seasonal Malaria Chemoprevention: Secondary Analyses of Data from a Clinical Trial in Houndé, Burkina Faso, and Bougouni, Mali (2021) (7)
- Presence of quintuple dhfr N51, C59, S108 - dhps A437, K540 mutations in Plasmodium falciparum isolates from pregnant women and the general population in Nanoro, Burkina Faso. (2017) (7)
- Severe anaemia associated with Plasmodium falciparum infection in children: consequences for additional blood sampling for research (2016) (7)
- Impact of the addition of azithromycin to antimalarials used for seasonal malaria chemoprevention on antimicrobial resistance of Streptococcus pneumoniae (2019) (6)
- Severe-malaria infection and its outcomes among pregnant women in Burkina Faso health-districts: Hierarchical Bayesian space-time models applied to routinely-collected data from 2013 to 2018 (2020) (6)
- Additional Screening and Treatment of Malaria During Pregnancy Provides Further Protection Against Malaria and Nonmalarial Fevers During the First Year of Life (2018) (6)
- Algorithms for sequential interpretation of a malaria rapid diagnostic test detecting two different targets of Plasmodium species to improve diagnostic accuracy in a rural setting (Nanoro, Burkina Faso) (2019) (6)
- Field evaluation of SD Bioline Malaria Antigen P.f(R) for Plasmodium falciparum malaria diagnosis in Nanoro, Burkina Faso (2015) (6)
- Maternal Malaria and Malnutrition (M3) initiative, a pooled birth cohort of 13 pregnancy studies in Africa and the Western Pacific (2016) (6)
- Safety and efficacy of the choline analogue SAR97276 for malaria treatment: results of two phase 2, open-label, multicenter trials in African patients (2017) (6)
- Testing an infection model to explain excess risk of preterm birth with long-term iron supplementation in a malaria endemic area (2019) (6)
- The effect of malaria on haemoglobin concentrations: a nationally representative household fixed-effects study of 17,599 children under 5 years of age in Burkina Faso (2021) (6)
- Decomposing multidimensional child poverty and its drivers in the Mouhoun region of Burkina Faso, West Africa (2020) (6)
- Changing Dietary Habits: The Impact of Urbanization and Rising Socio-Economic Status in Families from Burkina Faso in Sub-Saharan Africa (2022) (5)
- Genetic variation in the immune system and malaria susceptibility in infants: a nested case–control study in Nanoro, Burkina Faso (2021) (5)
- Efficacy and safety of pyronaridine/artesunate fixed-dose combination compared with mefloquine plus artesunate in patients with acute uncomplicated Plasmodium falciparum malaria: results of a pivotal phase III trial (2009) (5)
- Artemisinin resistance in rodent malaria - mutation in the AP2 adaptor μ-chain suggests involvement of endocytosis and membrane protein trafficking (2013) (5)
- [The simplified isotopic microtest: a method for studying the drug resistance in vitro of Plasmodium falciparum to antimalarial drugs]. (2000) (5)
- High adherence level to artemisinin-based combination therapies in rural settlement 11 years after their introduction in the health system, Nanoro, Burkina Faso (2019) (5)
- Risk of malaria in young children after periconceptional iron supplementation (2020) (5)
- Clinical Management and Mortality among COVID-19 Cases in Sub-Saharan Africa: A retrospective study from Burkina Faso and simulated case data analysis (2020) (5)
- Malaria and curable sexually transmitted infections in pregnant women: A two-years observational study in rural Burkina Faso (2020) (5)
- Use of WATCH antibiotics prior to presentation to the hospital in rural Burkina Faso (2021) (4)
- Iron Status of Burkinabé Adolescent Girls Predicts Malaria Risk in the Following Rainy Season (2020) (4)
- Antibiotic Susceptibility of Staphylococcus aureus and Streptococcus pneumoniae Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso (2021) (4)
- [In vitro susceptibility of 232 isolates of Plasmodium falciparum to antimalarials in Burkina Faso (West Africa)]. (2001) (4)
- Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso (2015) (4)
- Meta-analysis of sub-Saharan African studies provides insights into genetic architecture of lipid traits (2022) (4)
- Building momentum for malaria vaccine research and development: key considerations (2020) (4)
- Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01E malaria vaccine in African children: a randomized trial (2020) (4)
- Infection Manager System (IMS) as a new hemocytometry-based bacteremia detection tool: A diagnostic accuracy study in a malaria-endemic area of Burkina Faso (2021) (4)
- Metagenomic analysis of antimicrobial resistance genes in wastewaters in Benin and Burkina Faso indicates a serious health risk from untreated hospital wastewaters in low-income countries (2021) (4)
- Perspectives on the design and methodology of periconceptional nutrient supplementation trials (2016) (4)
- Interleukin-10 and soluble tumor necrosis factor receptor II are potential biomarkers of Plasmodium falciparum infections in pregnant women: a case-control study from Nanoro, Burkina Faso (2017) (4)
- Pooled Multicenter Analysis of Cardiovascular Safety and Population Pharmacokinetic Properties of Piperaquine in African Patients with Uncomplicated Falciparum Malaria (2020) (4)
- Genetic associations with carotid intima-media thickness link to atherosclerosis with sex-specific effects in sub-Saharan Africans (2022) (3)
- Can clinical signs or symptoms combined with basic hematology data be used to predict the presence of bacterial infections in febrile children under - 5 years? (2018) (3)
- Using health and demographic surveillance systems for teratovigilance in Africa. (2016) (3)
- Plasmodium falciparum gametocyte carriage in symptomatic patients shows significant association with genetically diverse infections, anaemia, and asexual stage density (2021) (3)
- Plasmodium falciparum sexual conversion rates can be affected by artemisinin-based treatment in naturally infected malaria patients (2022) (3)
- Red blood cell homeostasis in children and adults with and without asymptomatic malaria infection in Burkina Faso (2020) (3)
- Impact of a package of diagnostic tools, clinical algorithm, and training and communication on outpatient acute fever case management in low- and middle-income countries: protocol for a randomized controlled trial (2020) (3)
- An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso (2012) (3)
- Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change (2014) (3)
- Antibiotic susceptibility profile of bacterial isolates from febrile children under 5 years of age in Nanoro, Burkina Faso (2021) (3)
- COVID-19 epidemiological, sociological and anthropological investigation: study protocol for a multidisciplinary mixed methods research in Burkina Faso (2021) (3)
- Seasonal patterns of malaria, genital infection, nutritional and iron status in non-pregnant and pregnant adolescents in Burkina Faso: a secondary analysis of trial data (2021) (3)
- Strong off-target antibody reactivity to malarial antigens induced by RTS,S/AS01E vaccination is associated with protection (2022) (3)
- [In vivo sensitivity of Plasmodium faciparum to chloroquine and sulfadoxine pyrimethamine in the Bobo Dioulasso region (1998-2001): risk factors associated with treatments failures to the two drugs]. (2006) (3)
- Socioeconomic inequalities in curative healthcare-seeking for children under five before and after the free healthcare initiative in Sierra Leone: analysis of population-based survey data (2021) (3)
- Adiposity Phenotypes and Subclinical Atherosclerosis in Adults from Sub–Saharan Africa: An H3Africa AWI–Gen Study (2021) (3)
- Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study (2021) (3)
- Nutritional status in young children prior to the malaria transmission season in Burkina Faso and Mali, and its impact on the incidence of clinical malaria (2021) (2)
- Altered Ex-Vivo Cytokine Responses in Children With Asymptomatic Plasmodium falciparum Infection in Burkina Faso: An Additional Argument to Treat Asymptomatic Malaria? (2021) (2)
- Comparison of effectiveness of two different artemisinin-based combination therapies in an area with high seasonal transmission of malaria in Burkina Faso (2017) (2)
- Lessons learnt from 20 years surveillance of malaria drug resistance prior to the policy change in Burkina Faso. (2016) (2)
- Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data (2022) (2)
- Safety of antimalarial drug use during early pregnancy in Bobo Dioulasso: Examining low birth weight and congenital malformations as potential adverse outcomes (2017) (2)
- Effect of adding azithromycin to the antimalarials used for seasonal malaria chemoprevention on the nutritional status of African children (2020) (2)
- The Anti-Circumsporozoite Antibody Response of Children to Seasonal Vaccination With the RTS,S/AS01E Malaria Vaccine (2021) (2)
- Low birth weight and its associated risk factors in a rural health district of Burkina Faso: a cross sectional study (2022) (2)
- Age-modified factors associated with placental malaria in rural Burkina Faso (2022) (2)
- Pathogens associated with acute diarrhea, and comorbidity with malaria among children under five years old in rural Burkina Faso (2021) (2)
- Seasonal use case for the RTS,S/AS01 malaria vaccine: a mathematical modelling study. (2022) (2)
- Assessment of Recovery Time, Worsening, and Death among Inpatients and Outpatients with COVID-19, Treated with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso (2022) (2)
- Association of malaria and curable sexually transmitted infections with pregnancy outcomes in rural Burkina Faso (2021) (2)
- Cooperation in Countering Artemisinin Resistance in Africa: Learning from COVID-19 (2022) (2)
- Accuracy of Pf HRP2 versus Pf-pLDH antigen detection by malaria rapid diagnostic tests in hospitalized children in a seasonal hyperendemic malaria transmission area in Burkina Faso (2014) (2)
- HEALTH AND DEMOGRAPHIC SURVEILLANCE SYSTEM PROFILE Profile : Nanoro Health and Demographic Surveillance System (2012) (2)
- Impact of mass administration of azithromycin as a preventive treatment on the prevalence and resistance of nasopharyngeal carriage of Staphylococcus aureus (2021) (1)
- Nasopharyngeal colonisation dynamics of bacterial pathogens in patients with fever in rural Burkina Faso: an observational study (2022) (1)
- How to Estimate Optimal Malaria Readiness Indicators at Health-District Level: Findings from the Burkina Faso Service Availability and Readiness Assessment (SARA) Data (2020) (1)
- Development and evaluation of an electronic algorithm using a combination of a two-step malaria RDT and other rapid diagnostic tools for the management of febrile illness in children under 5 attending outpatient facilities in Burkina Faso (2022) (1)
- Pre-delivery administration of azithromycin to prevent neonatal sepsis and death: a phase iii double-blind randomized clinical trial (PregnAnZI-2 trial) (2022) (1)
- Pregnancy outcomes after first-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: a systematic review and individual patient data meta-analysis (2022) (1)
- A pooled analysis of the duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine (2019) (1)
- Author Correction: Meta-analysis of sub-Saharan African studies provides insights into genetic architecture of lipid traits (2022) (1)
- Prevalence and risk factors of malaria among first antenatal care attendees in rural Burkina Faso (2022) (1)
- Prevalence and factors associated with carriage of Pfmdr1 polymorphisms among pregnant women receiving intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) and artemether-lumefantrine for malaria treatment in Burkina Faso (2020) (1)
- [Parasitological resistance of Plasmodium falciparum to antimalarial drugs: what physicians should keep in mind]. (2004) (1)
- Clinical signs and symptoms cannot reliably predict Plasmodium falciparum malaria infection in pregnant women living in an area of high seasonal transmission (2013) (1)
- Malaria and curable sexually transmitted and reproductive tract coinfection among pregnant women in rural Burkina Faso (2021) (1)
- Bacterial Contamination of Antiseptics, Disinfectants, and Hand Hygiene Products Used in Healthcare Settings in Low- and Middle-Income Countries—A Systematic Review (2023) (1)
- Serotype Profile of Nasopharyngeal Isolates of Streptococcus pneumoniae Obtained from Children in Burkina Faso before and after Mass Administration of Azithromycin (2020) (1)
- Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy (2019) (1)
- Selection of Plasmodium falciparum Pfmdr-1 N86Y alleles by Amodiaquine-Artesunate and Artemether-Lumefantrine in Nanoro, Burkina Faso (2016) (1)
- Correction: Diagnosis of Bacterial Bloodstream Infections: A 16S Metagenomics Approach (2017) (1)
- Effi cacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of fi rst-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial (2017) (1)
- Prospective observational study to evaluate the clinical and biological safety profile of pyronaridine–artesunate in a rural health district in Burkina Faso (2022) (1)
- The impact of clinical research activities on communities in rural Africa: the development of the Clinical Research Unit of Nanoro (CRUN) in Burkina Faso (2014) (1)
- Effect of seasonal malaria chemoprevention plus azithromycin on Plasmodium falciparum transmission: gametocyte infectivity and mosquito fitness (2021) (1)
- Magnitude of low birthweight in malaria endemic settings of Nanoro, rural Burkina Faso: a secondary data analysis (2021) (1)
- Building momentum for malaria vaccine research and development: key considerations (2020) (1)
- Household costs associated with seeking malaria treatment during pregnancy: evidence from Burkina Faso and The Gambia (2020) (1)
- Fetal biometry assessment with Intergrowth 21st’s and Salomon’s equations in rural Burkina Faso (2020) (1)
- Genomic Epidemiology of SARS-CoV-2 in Western Burkina Faso, West Africa (2022) (1)
- Effect of Intrapartum Azithromycin vs Placebo on Neonatal Sepsis and Death: A Randomized Clinical Trial. (2023) (1)
- Assessment of a combined strategy of seasonal malaria chemoprevention and supplementation with vitamin A, zinc and Plumpy’Doz™ to prevent malaria and malnutrition in children under 5 years old in Burkina Faso: a randomized open-label trial (SMC-NUT) (2021) (1)
- Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Burkina Faso: an open label trial (2019) (1)
- Investigating COVID-19 in Low-income Settings: Protocol for a Multidisciplinary Mixed Methods Research in Burkina Faso (2021) (0)
- Use of WATCH antibiotics prior to presentation to the hospital in rural Burkina Faso (2022) (0)
- Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso (2015) (0)
- Fear and rumours regarding placental biopsies in a malaria-in-pregnancy trial in Benin (2018) (0)
- The duration of protection against clinical malaria provided by the combination of seasonal RTS,S/AS01E vaccination and seasonal malaria chemoprevention versus either intervention given alone (2022) (0)
- Perspective Piece: Good Clinical Practice in Resource-Limited Settings: Translating Theory into Practice (2013) (0)
- valea PK meflo pregnancy may 2014 JAC (2014) (0)
- Profile of drug use during pregnancy at peripheral health centres in Burkina Faso (2018) (0)
- List of contributors (2020) (0)
- Impact of Intra-Partum Azithromycin on Neonatal Sepsis and Death and Maternal Infections in the Gambia and Burkina Faso: A Double-Blind Placebo-Controlled Trial (2022) (0)
- Patterns of child mortality in rural area of Burkina Faso: evidence from the Nanoro health and demographic surveillance system (HDSS) (2021) (0)
- Paracheck® rapid diagnostic test for detecting malaria infection in under five children: a population-based survey in Burkina Faso (2014) (0)
- Title Failure to detect Plasmodium vivax in West and Central Africa by PCRspecies typing (2017) (0)
- Cardiovascular safety and population pharmacokinetic properties of piperaquine in African patients with uncomplicated falciparum malaria - a pooled multicentre analysis. (2020) (0)
- High titres of immunoglobulin g class 1 antibodies to duffy binding-like (DBL) 5 during the third trimester of pregnancy are associated with past placental malaria at delivery in an area of high seasonal transmission in Burkina Faso. (2018) (0)
- Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Burkina Faso: an open label trial (2019) (0)
- The simplified isotopic microtest: a method for studying the susceptibility in vitro of Plasmodium falciparum to antimalarial drugs (2000) (0)
- Artemisinin-based combination therapy during pregnancy: outcome of pregnancy and infant mortality: a cohort study (2019) (0)
- Impact and operational feasibility of adding malaria infection screening using an ultrasensitive RDT for placental and fetal outcomes in an area of high IPTP-SP coverage in Burkina Faso: the ASSER MALARIA pilot study protocol (2022) (0)
- Associations between dental problems and underweight status among rural women in Burkina Faso: results from the first WHO Stepwise Approach to Surveillance (STEPS) survey (2021) (0)
- Could combined rapid diagnostic testing for malaria and c-reactive protein be helpful for the diagnosis and management of febrile illnesses in children under-5 years of age in rural Burkina Faso? (2022) (0)
- AZ-SMC Trial - School child parasitaemia dataset (2020) (0)
- AZ-SMC Trial - Drug administration dataset (2020) (0)
- Interleukin-10 and soluble tumor necrosis factor receptor II are potential biomarkers of Plasmodium falciparum infections in pregnant women: a case-control study from Nanoro, Burkina Faso (2017) (0)
- Assessment of the performance of malaria rapid diagnostic test in acutely malnourished children under five years of age in Nanoro - Burkina Faso (2020) (0)
- Genetic associations with carotid intima-media thickness link to atherosclerosis biology with sex-differences in sub-Saharan Africans (2021) (0)
- Effect of seasonal malaria chemoprevention plus azithromycin on Plasmodium falciparum transmission: gametocyte infectivity and mosquito fitness (2021) (0)
- Safety and efficacy of the choline analogue SAR97276 for malaria treatment: results of two phase 2, open-label, multicenter trials in African patients (2017) (0)
- Incidence of adverse drug reactions resulting from the use of Amodiaquine-Artesunate in Nanoro, Burkina Faso (2017) (0)
- Diagnostic Performance of Plasmodium falciparum Histidine-Rich Protein-2 Antigen-Specific Rapid Diagnostic Test in Children at the Peripheral Health Care Level in Nanoro (Burkina Faso) (2022) (0)
- AZ-SMC Trial - Weekly survey dataset (2020) (0)
- Spatial patterns of child mortality in Nanoro HDSS site, Burkina Faso (2020) (0)
- Escherichia coli from urine samples of pregnant women as an indicator for antimicrobial resistance in the community: a field study from rural Burkina Faso (2022) (0)
- Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine (2017) (0)
- First trimester use of artemisinin-based combination therapy and the risk of low birth weight and small for gestational age (2020) (0)
- Genetic variation in the immune system and malaria susceptibility in infants: a nested case–control study in Nanoro, Burkina Faso (2021) (0)
- Data repository for AZ-SMC - a trial of seasonal malaria chemoprevention combined with azithromycin in African children (2020) (0)
- How to Optimally Estimate Malaria Readiness Indicators at the Health district Level? Findings from the Burkina Faso Service Availability and Readiness Assessment (SARA) Cross-Sectional Data (2019) (0)
- Asymptomatic bacteriuria in pregnant women as a proxy for antibiotic resistance surveillance in the community: preliminary results from a study in Nanoro, rural Burkina Faso (2017) (0)
- Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine–pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso (2017) (0)
- THE ADDED VALUE OF A MULTICOUNTRY NETWORK FOR PROMOTING ETHICAL AND REGULATORY STANDARDS IN CLINICAL TRIALS IN LOW- AND MIDDLE-INCOME COUNTRIES: THE EXPERIENCE OF THE ‘SWITCHING THE POLES NETWORK’ (2017) (0)
- SAFETY AND EFFICACY OF SAR97276A FOR TREATING MALARIA: TWO OPEN-LABEL MULTICENTER PHASE II CLINICAL STUDIES IN AFRICAN CHILDREN AND ADULTS (2017) (0)
- Malaria incidence and prevalence during the first year of life in Nanoro, Burkina Faso: a birth-cohort study (2018) (0)
- Plasmodium falciparum gametocyte carriage in symptomatic patients shows significant association with genetically diverse infections, anaemia, and asexual stage density (2021) (0)
- Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®) (2015) (0)
- Prevalence and factors associated with carriage of Pfmdr1 polymorphisms among pregnant women receiving intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) and artemether-lumefantrine for malaria treatment in Burkina Faso (2020) (0)
- Antimicrobial resistance diagnostic use accelerator – Behavioural determinants of point-of-care diagnostic uptake, and adherence to prescription (2020) (0)
- Comparison of intermittent screening (using ultra-sensitive malaria rapid diagnostic test) and treatment (using a newly registered antimalarial pyronaridine-artesunate—PYRAMAX®) to standard intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria in pregnant wom (2022) (0)
- Strong off-target antibody reactivity to malarial antigens induced by RTS,S/AS01E vaccination is associated with increased protection (2021) (0)
- Performance of PfHRP2-RDT for malaria diagnosis during the first year of life in a high malaria transmission area in Burkina Faso (2023) (0)
- The effect of malaria on haemoglobin concentrations: a nationally representative household fixed-effects study of 17,599 children under 5 years of age in Burkina Faso (2021) (0)
- Genetic associations with carotid intima-media thickness link to atherosclerosis with sex-specific effects in sub-Saharan Africans (2022) (0)
- Impact of seasonal RTS,S/AS01E vaccination plus seasonal malaria chemoprevention on the nutritional status of children in Burkina Faso and Mali (2022) (0)
- Diagnosing congenital malaria in a high-transmission setting: clinical relevance and usefulness of P. falciparum HRP2-based testing (2017) (0)
- A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria (2021) (0)
- Development and evaluation of simplified molecular diagnostic devices for malaria (2011) (0)
- Boosting the impact of seasonal malaria chemoprevention (SMC) through simultaneous screening and treatment of household members of children receiving SMC in Burkina Faso: a protocol for a randomized open label trial (2022) (0)
- Exploring the behavioural determinants of adherence to prescription for acute febrile illnesses, and development of a training and communication clinical trial intervention: a description of research methods. (2020) (0)
- Nanoro , Burkina Faso (2018) (0)
- Severe anaemia associated with Plasmodium falciparum infection in children: consequences for additional blood sampling for research (2016) (0)
- Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countries (2017) (0)
- Repeated Artemisinin-based combination treatment and dynamics of Plasmodium falciparum strains in Uganda and the Democratic Republic of the Congo (2017) (0)
- Host-mediated selection impacts the diversity of Plasmodium falciparum antigens within infections (2018) (0)
- Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malaria (2023) (0)
- Nutritional status in young children prior to the malaria transmission season in Burkina Faso and Mali, and its impact on the incidence of clinical malaria (2021) (0)
- Screening and Treating Malaria in Pregnancy by Community Health Workers in Benin, Burkina Faso and Gambia: Profiles, Perceptions and Time Commitments (2020) (0)
- [Polymorphisms in Plasmodium falciparum parasites and mutations in the resistance genes Pfcrt and Pfmdr1 in Nanoro area, Burkina Faso]. (2021) (0)
- Escherichia coli from urine samples of pregnant women as an indicator for antimicrobial resistance in the community: a field study from rural Burkina Faso (2021) (0)
- Engaging the public in priority setting for nutrition in Sub-Saharan Africa (2021) (0)
- The effect of malaria rapid diagnostic tests results on antimicrobial prescription practices of health care workers in Burkina Faso (2019) (0)
- Excess risk of preterm birth with periconceptional iron supplementation in a malaria endemic area: analysis of secondary data on birth outcomes in a double blind randomized controlled safety trial in Burkina Faso (2019) (0)
- The Effect of Malaria on Haemoglobin Concentrations in Extreme Poverty: A Nationally Representative Household Fixed-Effects Study of 17 599 Children under 5 Years of Age in Burkina Faso. (2021) (0)
- Abstracts of the Eighth EDCTP Forum, 6–9 November 2016 (2017) (0)
- Effects of maternal antenatal treatment with two doses of azithromycin added to monthly sulfadoxine-pyrimethamine for the prevention of low birth weight in Burkina Faso: an open-label randomized controlled trial (2023) (0)
- Cross-sectional analysis in young non-pregnant and pregnant women in Burkina Faso of associations between biomarkers of iron status and effect modification by inflammation and P. falciparum infection (2017) (0)
- Comparison of severity signs between patients with primary and secondary dengue infection during the 2016 Burkina Faso (West Africa) outbreak. (2020) (0)
- In vivo/ex vivo efficacy of artemether–lumefantrine and artesunate–amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso (2020) (0)
- Implementation of a malaria rapid diagnostic test in a rural setting of Nanoro, Burkina Faso: from expectation to reality (2018) (0)
- Increase in the prevalence of mutations associated with sulfadoxine–pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso (2017) (0)
- Investing in human development and building state resilience in fragile contexts: A case study of early nutrition investments in Burkina Faso (2023) (0)
- Healthcare seeking outside healthcare facilities and antibiotic dispensing patterns in rural Burkina Faso: A mixed methods study (2023) (0)
- Phase 3 Evaluation of an Innovative Simple Molecular Test for the Diagnosis of Malaria and Follow-Up of Treatment Efficacy in Pregnant Women in Sub-Saharan Africa (Preg-Diagmal) (2022) (0)
- Testing an infection model to explain excess risk of preterm birth with long-term iron supplementation in a malaria endemic area (2019) (0)
- Explorer Artemisinin resistance in rodent malaria-mutation in the AP 2 adaptor-chain suggests involvement of endocytosis and membrane protein trafficking (2018) (0)
- Spatiotemporal changes of malaria in pregnancy in Burkina Faso 2015–2017: a hierarchical Bayesian approach using routinely-collected health data (2019) (0)
- Accuracy of a Plasmodium falciparum specific histidine-rich protein 2 rapid diagnostic test in the context of the presence of non-malaria fevers, prior anti-malarial use and seasonal malaria transmission (2017) (0)
- A microplanning model to improve door-to-door health service delivery: the case of Seasonal Malaria Chemoprevention in Sub-Saharan African villages (2020) (0)
- Histidine-rich protein-2 based malaria rapid diagnostic tests performance among febrile pregnant women in high malaria transmission area (2021) (0)
- Effectiveness and safety of artemether–lumefantrine versus artesunate–amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial (2015) (0)
- THE INTERNATIONAL GOOD CLINICAL PRACTICES GUIDELINES: TIME FOR A REVISION? (2017) (0)
- Intermediate hepatitis B virus infection prevalence among 1622 pregnant women in rural Burkina Faso and implications for mother-to-child transmission (2023) (0)
- Setting a realistic AWaRe target for primary care antibiotic use in LMICs. (2023) (0)
- Phase 3 evaluation of an innovative simple molecular test for the diagnosis of malaria in different endemic and health settings in sub-Saharan Africa (DIAGMAL) (2022) (0)
- Determinants of asymptomatic malaria risk among children under 5 years in Burkina Faso: A bayesian with spatial dependance approach (2018) (0)
- Bayesian Spatiotemporal Modeling of Routinely Collected Data to Assess the Effect of Health Programs in Malaria Incidence During Pregnancy in Burkina Faso (2020) (0)
- Epidemiologic profile of hepatitis C virus infection and genotype distribution in Burkina Faso: a systematic review with meta-analysis (2021) (0)
- Assessment of halofantrine therapeutic effectiveness and in vitro antimalarial drug susceptibility in burkina faso (1998) (0)
- Drug safety in Burkina Faso (2020) (0)
- AZ-SMC Trial - Cross-sectional dataset (2020) (0)
- Environmental characteristics and evolution of malaria hotspots in a rural area, Burkina Faso. In Tropical Medicine and International Health (2017) (0)
- Bacterial Contamination of Antiseptics, Disinfectants and Hand Hygiene Products in Healthcare Facilities in High-Income Countries: A Scoping Review (2023) (0)
- Asymptomatic malaria and anaemia among pregnant women during high and low malaria transmission seasons in Burkina Faso: household-based cross-sectional surveys in Burkina Faso, 2013 and 2017 (2021) (0)
- Socioeconomic Inequalities in Care-Seeking for Children Under Five Before and After the Free Healthcare Initiative in Sierra Leone: An Analysis of Population-Based Survey Data (2020) (0)
- Metagenomic Analysis of the Abundance and Composition of Antibiotic Resistance Genes in Hospital Wastewater in Benin, Burkina Faso, and Finland (2023) (0)
- Spatial distribution and determinants of asymptomatic malaria risk among children under 5 years in 24 districts in Burkina Faso (2018) (0)
- Genetically diverse Plasmodium falciparum infections, within-host competition and symptomatic malaria in humans (2019) (0)
- Impact of seasonal RTS,S/AS01E vaccination plus seasonal malaria chemoprevention on the nutritional status of children in Burkina Faso and Mali (2022) (0)
- Title Community-based scheduled screening and treatment of malaria in pregnancy for improved maternal and infant health in The Gambia , Burkina Faso and Benin : study protocol for a randomized controlled trial (2018) (0)
- Maternal factors of newborn low birthweight in malaria endemic settings of Nanoro, rural Burkina Faso (2020) (0)
- Extending the reach of Seasonal Malaria Chemoprevention in Sub-Saharan Africa: A microplanning model to improve door-to-door health service delivery (2020) (0)
- The effect of malaria on childhood anemia in a quasi-experimental study of 7,384 twins from 23 Sub-Saharan African countries (2022) (0)
- Antibiotic susceptibility profile of bacterial pathogens isolated from febrile children under 5 years of age in Nanoro, Burkina Faso (2020) (0)
This paper list is powered by the following services:
Other Resources About Halidou Tinto
What Schools Are Affiliated With Halidou Tinto?
Halidou Tinto is affiliated with the following schools:
